#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	3858	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2923	389.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1957	1957	C	519	C	486	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6186	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4289	432.7	0	.	n	.	0	T695C	SNP	695	695	T	1457	1457	C	451	C,A	402,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6186	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4289	432.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	2099	2099	A	558	A	526	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6186	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4289	432.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2733	2733	C	598	C,G	555,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6186	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4289	432.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2807	2807	A	630	A	581	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6186	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4289	432.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3359	3359	C	523	C,T	468,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	574	folP	852	852	100.0	folP.l6.c17.ctg.1	2061	83.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1278	1280	AGC	133;135;135	A;G;C	121;124;121	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1230	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4201	87.8	1	SNP	p	S91F	0	.	.	271	273	TCC	1037	1039	TCC	115;114;113	T;C;C	102;109;107	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1230	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4201	87.8	1	SNP	p	D95G	0	.	.	283	285	GAC	1049	1051	GAC	112;114;112	G;A;C	104;107;107	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1230	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4201	87.8	1	SNP	p	D95N	0	.	.	283	285	GAC	1049	1051	GAC	112;114;112	G;A;C	104;107;107	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.Neisseria_meningitidis_serogroup_A_Z2491_v1_01888	mtrR.Neisseria_meningitidis_serogroup_A_Z2491_v1_01888	1	1	539	532	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1848	86.3	0	.	p	.	0	A40P	NONSYN	118	120	GCC	734	736	CCC	118;118;120	C,T;C;C	108,1;109;107	.	.
mtrR.Neisseria_meningitidis_serogroup_A_Z2491_v1_01888	mtrR.Neisseria_meningitidis_serogroup_A_Z2491_v1_01888	1	1	539	532	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1848	86.3	1	SNP	p	G45D	0	.	.	133	135	GGC	749	751	GGC	122;121;122	G;G;C	111;107;113	mtrR.Neisseria_meningitidis_serogroup_A_Z2491_v1_01888:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1310	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3343	117.0	1	SNP	p	D86N	0	.	.	256	258	GAC	772	774	GAC	127;127;128	G;A;C	114;109;117	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1310	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3343	117.0	1	SNP	p	S87I	0	.	.	259	261	AGT	775	777	AGT	125;124;123	A;G;T	112;117;116	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1310	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3343	117.0	1	SNP	p	S87W	0	.	.	259	261	AGT	775	777	AGT	125;124;123	A;G;T	112;117;116	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1310	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3343	117.0	1	SNP	p	S87R	0	.	.	259	261	AGT	775	777	AGT	125;124;123	A;G;T	112;117;116	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1310	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3343	117.0	1	SNP	p	S88P	0	.	.	262	264	TCC	778	780	TCC	124;123;124	T;C;C	117;117;118	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	910	parE	1986	1986	100.0	parE.l6.c30.ctg.1	3469	78.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	2172	2174	GGC	117;117;117	G,A;G,T;C	108,1;107,1;105	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3145	78.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1583	1585	GCA	111;113;113	G,T,A;C;A	98,1,1;102;104	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3145	78.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1586	1588	ATC	113;113;113	A;T;C	104;103;101	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3145	78.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1598	1600	GTG	114;113;114	G;T;G	106;106;105	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3145	78.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1598	1600	GTG	114;113;114	G;T;G	106;106;105	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3145	78.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2102	2104	ACC	91;91;91	A;C;C	79;81;86	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3145	78.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2156	2158	GCG	81;81;80	G;C,G;G	71;63,1;61	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3145	78.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2156	2158	GCG	81;81;80	G;C,G;G	71;63,1;61	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3145	78.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2279	2281	GGC	93;93;93	G,C;G;C	82,2;83;82	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3145	78.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2288	2290	GGC	94;94;95	G,T;G;C	78,1;82;84	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	822	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3145	78.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2306	2308	CCG	96;97;96	C;C;G	80;87;81	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1366	ponA	2397	2397	99.96	ponA.l6.c17.ctg.1	3559	114.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1862	1864	CTG	122;124;123	C,T;T,G;G	111,1;114,1;113	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	566	porA	1146	1146	99.83	porA.l6.c4.ctg.1	2329	72.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	836	836	C	92	C	84	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	636	porB1b	1035	1035	95.63	porB1b.l15.c4.ctg.1	2041	91.1	0	.	p	.	0	E41K	NONSYN	121	123	GAA	840	842	AAA	148;148;149	A,G;A;A	128,1;130;132	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	636	porB1b	1035	1035	95.63	porB1b.l15.c4.ctg.1	2041	91.1	0	.	p	.	0	E48K	NONSYN	142	144	GAA	861	863	AAA	143;143;142	A,G;A;A	129,1;130;128	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	636	porB1b	1035	1035	95.63	porB1b.l15.c4.ctg.1	2041	91.1	0	.	p	.	0	F135L	NONSYN	403	405	TTT	1122	1124	CTT	128;128;128	C,G;T;T,A	121,1;117;116,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	636	porB1b	1035	1035	95.63	porB1b.l15.c4.ctg.1	2041	91.1	0	.	p	.	0	R143G	NONSYN	427	429	AGA	1146	1148	GGA	129;129;129	G,C;G,A;A	120,1;119,1;122	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	636	porB1b	1035	1035	95.63	porB1b.l15.c4.ctg.1	2041	91.1	0	.	p	.	0	D171G	NONSYN	511	513	GAT	1230	1232	GGT	128;128;128	G;G,A;T,C	114;118,1;120,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	636	porB1b	1035	1035	95.63	porB1b.l15.c4.ctg.1	2041	91.1	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1284	1286	AGC	116;116;117	A;G,A;C	108;110,1;114	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	636	porB1b	1035	1035	95.63	porB1b.l15.c4.ctg.1	2041	91.1	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1350	1350	T	120	T	108	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	636	porB1b	1035	1035	95.63	porB1b.l15.c4.ctg.1	2041	91.1	1	SNP	p	G120K	0	.	.	358	360	GGT	1077	1079	GGT	127;127;127	G;G;T	118;113;118	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	636	porB1b	1035	1035	95.63	porB1b.l15.c4.ctg.1	2041	91.1	1	SNP	p	A121D	0	.	.	361	363	GCC	1080	1082	GCC	126;128;129	G;C;C	108;119;115	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	636	porB1b	1035	1035	95.63	porB1b.l15.c4.ctg.1	2041	91.1	1	SNP	p	A121N	0	.	.	361	363	GCC	1080	1082	GCC	126;128;129	G;C;C	108;119;115	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2270	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5425	125.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2243	2245	AAT	133;134;133	A;A;T	119;125;124	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	406	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1480	81.6	1	SNP	p	V57M	1	.	.	169	171	ATG	763	765	ATG	142;142;143	A;T;G	129;130;131	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
